Russell Investments Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05K | Sell |
742
-1,352
| -65% | -$1.92K | ﹤0.01% | 3666 |
|
|
2025
Q1 | $3.2K | Sell |
2,094
-671
| -24% | -$1.03K | ﹤0.01% | 3438 |
|
|
2024
Q4 | $6.86K | Hold |
2,765
| – | – | ﹤0.01% | 3221 |
|
|
2024
Q3 | $3.18K | Sell |
2,765
-785
| -22% | -$903 | ﹤0.01% | 3304 |
|
|
2024
Q2 | $3.91K | Sell |
3,550
-59,222
| -94% | -$65.1K | ﹤0.01% | 3265 |
|
|
2024
Q1 | $77.8K | Buy |
62,772
+61,602
| +5,265% | +$76.4K | ﹤0.01% | 2604 |
|
|
2023
Q4 | $1.23K | Buy |
1,170
+1,137
| +3,445% | +$1.19K | ﹤0.01% | 3046 |
|
|
2023
Q3 | $226 | Buy |
+33
| New | +$226 | ﹤0.01% | 3478 |
|
|
2018
Q4 | – | Sell |
-103,185
| Closed | -$1.5M | – | 2904 |
|
|
2018
Q3 | $1.5M | Buy |
103,185
+29,645
| +40% | +$431K | ﹤0.01% | 1905 |
|
|
2018
Q2 | $1.47M | Buy |
73,540
+24,090
| +49% | +$481K | ﹤0.01% | 1924 |
|
|
2018
Q1 | $867K | Buy |
49,450
+3,421
| +7% | +$60K | ﹤0.01% | 2262 |
|
|
2017
Q4 | $1.16M | Buy |
46,029
+3,182
| +7% | +$80K | ﹤0.01% | 2081 |
|
|
2017
Q3 | $1.11M | Buy |
42,847
+1,352
| +3% | +$34.9K | ﹤0.01% | 2093 |
|
|
2017
Q2 | $1.13M | Sell |
41,495
-2,792
| -6% | -$75.8K | ﹤0.01% | 2050 |
|
|
2017
Q1 | $1.32M | Sell |
44,287
-7,837
| -15% | -$234K | ﹤0.01% | 1957 |
|
|
2016
Q4 | $1.41M | Buy |
+52,124
| New | +$1.41M | ﹤0.01% | 2003 |
|